Orexin Shows How The Genome Shapes Sleep And Narcolepsy

Orexin reveals how a small brain peptide controls wakefulness, explains narcolepsy, and inspires new treatments—and a search for the genome’s hidden proteins.

‘GTA 6’ Will Face Something It Couldn’t Have Prepared For At Launch

GTA 6 is running into a new industry change that could prove to be friend or foe, depending on how gamers wield it.

The Era Of AI Choice: Why Winning Companies Make Fewer Bets, Not More

In an era of nearly unlimited technological choice, knowing what not to chase may become just as important as knowing what to pursue.

The Two Worst Words In Enterprise AI

Every low-stakes approval spends down a budget you will need later, for the one decision that actually mattered.

‘You Can See Everything’ Breaks The All-Time IMDb Review Score Record

You Can See Everything is now the best-reviewed movie in IMDb history, alongside its Metacritic, Letterboxd and Rotten Tomatoes records.

Mandates For CIOs In The Token Economy

The mindset should be far more complex than “How many tokens did we consume?” Instead, consider the ROI of each token.

Apple’s $5 Trillion Market Cap Seems Too High Given 11% Growth View

Apple is growing too slowly and has too little profit to be worth $5 trillion. CEO John Ternus may not add enough revenue to justify 35 Forward PE.

Where ‘Street Fighter’ Audience Review Scores Land In The Video Game Movie List

Here’s how Street Fighter ranks among all video game adaptations ever in terms of Rotten Tomatoes audience scores.

​Why Family Law Firms Need An Intelligence Layer

For years, the legal profession has asked which firms will adopt AI. That question is becoming obsolete.

Don’t Kill The Golden Goose: Rectifying AI Cost Without Stifling Innovation

A cheap failed run still leaves the bug unsolved. What’s important is cost per solved problem or, put differently, token ROI.